Trial intelligence / Profile preview

Nalbuphine with ciprofol vs propofol for digestive endoscopy anesthesia

ChiCTR2500113434Phase 4Completed

Sponsor
Eighth Affiliated Hospital of Sun Yat-sen University
Start
Nov 2025
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in None comparing nalbuphine + ciprofol with Control: nalbuphine + propofol (2 arms). Primary endpoints: Injection pain and Incidence of hypotension. Started Nov 2025; status: completed.

02

Drugs

ciprofolpropofolnalbuphine

Beyond the preview

Go deeper on ChiCTR2500113434.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500113434.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call